Table 4 Demographics and clinical data of the studied patients

Demographics

 OBS

2,586

1,886(0.73)

700(0.27)

1,764

967(0.55)

797(0.45)

 Age^a

53.8 ± 0.5

56.4 ± 0.3

51.1 ± 0.7

55.6 ± 0.4

55.5 ± 0.4

55.7 ± 0.4

 BMI^a

25.3 ± 0.1

25.3 ± 0.1

25.2 ± 0.1

34.9 ± 0.2

33.8 ± 0.1

35.9 ± 0.2

 CAD

2,221

1,189(0.54)

1,032(0.46)

2,429

1,860(0.66)

569(0.34)

 MI

1,590

787(0.49)

803(0.51)

3,060

2,262(0.74)

798(0.26)

 FH

3,730

2,449(0.66)

1,283(0.34)

920

602(0.65)

318(0.35)

 T2DM

2,090

1,336(0.64)

754(0.36)

2,560

1,713(0.55)

847(0.45)

 HTN

1,109

735(0.66)

374(0.34)

3,541

2,314(0.65)

1,227(0.35)

 lHDLC

2,516

1,487(0.59)

1,029(0.41)

1,935

1,487(0.77)

448(0.23)

 hLDLC

3,696

2,449(0.75)

1,029(0.25)

860

634(0.74)

226(0.26)

 hChol

2,744

1,801(0.66)

943(0.34)

1,686

1,117(0.66)

569(0.34)

 hTG

3,168

2,028(0.64)

1,140(0.36)

1,166

829(0.71)

337(0.29)

 Smokers

2,791

1,314(0.47)

1,477(0.53)

1,771

1,694(0.96)

77(0.04)

Clinical characteristics (relative to coronary artery disease)

 Age

50.6 ± 0.4

51.2 ± 0.5

49.8 ± 0.5

60.3 ± 0.2

59.8 ± 0.3

61.8 ± 0.54

 BMI

29.0 ± 0.2

27.97 ± 0.2

30.3 ± 0.3

28.9 ± 0.1

28.3 ± 0.1

31.0 ± 0.3

 Total chol

4.51 ± 0.02

4.42 ± 0.03

4.62 ± 0.03

4.48 ± 0.02

4.43 ± 0.03

4.66 ± 0.05

 HDL-chol

1.26 ± 0.01

1.18 ± 0.03

1.33 ± 0.01

1.15 ± 0.01

1.15 ± 0.01

1.25 ± 0.02

 LDL-chol

2.76 ± 0.02

2.73 ± 0.03

2.80 ± 0.03

2.71 ± 0.02

2.68 ± 0.02

2.84 ± 0.06

 TG

1.52 ± 0.02

1.60 ± 0.03

1.44 ± 0.03

1.78 ± 0.02

1.78 ± 0.03

1.78 ± 0.05

 FG

6.87 ± 0.16

6.80 ± 0.23

6.92 ± 0.22

9.45 ± 0.31

9.27 ± 0.37

9.88 ± 0.56

 BP

120/83

119/81

121/82

128/84

130/85

127/83